NMT Group PLC
16 January 2004
16 January 2004
NMT Group PLC
Board Changes and Restructuring Update
Further to the announcement of 9 December 2003, NMT today provides an update on
progress with restructuring the Company.
As announced in December, the Company's production facility in Livingston,
Scotland has ceased to operate with the loss of approximately 140 jobs. The
remaining staff will form the core of a Development and Licensing Company with
the brief to optimise the intellectual property surrounding 2nd Generation
syringe technology and a range of safe needle pre-fill solutions for the
pharmaceutical industry.
Reflecting the reduced size and different nature of the Company, the following
Board changes will be made. Dr. Roger Gilmour, Non-executive Chairman, and Lady
Balfour of Burleigh Non-executive Director have both resigned today from the
Board of the Company. Tony Fletcher will undertake the role of Non-executive
Chairman with immediate effect, and Laurie Rostron will remain as a
Non-executive Director.
Roy Smith, Chief Executive Officer, will remain with the Company until the new
organisation is fully operational and a suitable handover is completed.
Additionally, Gerard Cassels, Group Finance Director, will remain with the
Company until the administrative duties surrounding the closure of the
Livingston facility are completed.
Commenting on the above, Tony Fletcher, Chairman stated: 'Our immediate
objective is to re-size the organisation and cost structure of the business
appropriate to the future planned development and licensing activities.
'We continue to believe that our intellectual property platform remains strong,
and are in discussions with several companies on the commercialisation of our
technology. We will continue to keep all future options for the business under
review.
'I would like to express my appreciation for the contribution that Dr. Gilmour
and Lady Balfour of Burleigh have made in guiding the Company over the past six
years.'
Enquiries:
NMT Group PLC
Tony Fletcher, Chairman Tel: 01506 445004
Gerard Cassels, Group Finance Director Tel: 01506 445004
Financial Dynamics Tel: 0207 831 3113
David Yates / Sarah MacLeod
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.